Chinese english Germany Japanese Korea

NVP-CLR457

NVP-CLR457 Struktur
1453082-52-4
CAS-Nr.
1453082-52-4
Englisch Name:
NVP-CLR457
Synonyma:
NVP-CLR457;2-Oxazolidinone, 3-[2'-amino-2-(4-morpholinyl)-4'-(trifluoromethyl)[4,5'-bipyrimidin]-6-yl]-4-(hydroxymethyl)-5-methyl-, (4S,5R)-;(4S,5R)-3-[6-[2-amino-4-(trifluoromethyl)-5-pyrimidinyl]-2-(4-morpholinyl)-4-pyrimidinyl]-4-(hydroxymethyl)-5-methyl-2-oxazolidinone
CBNumber:
CB811497756
Summenformel:
C18H20F3N7O4
Molgewicht:
455.39
MOL-Datei:
1453082-52-4.mol
Request For Quotation

NVP-CLR457 Eigenschaften

Siedepunkt:
732.1±70.0 °C(Predicted)
Dichte
1.481±0.06 g/cm3(Predicted)
pka
14.49±0.10(Predicted)

Sicherheit

NVP-CLR457 Chemische Eigenschaften,Einsatz,Produktion Methoden

NVP-CLR457 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

NVP-CLR457 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED 		+undefined-21-51877795
ivan@atkchemical.com China 32715 60
ShangHai Caerulum Pharma Discovery Co., Ltd. 18149758185
 sales-cpd@caerulumpharma.com China 3423 58
DC Chemicals 021-58447131 13564518121
 sales@dcchemicals.com China 9414 58
Suzhou youruike Chemical Pharmaceutical Technology Co., Ltd 15317229551
 15151849396@163.com China 997 58
TargetMol Chemicals Inc. 4008200310
 marketing@tsbiochem.com China 24018 58
Nantong QuanYi Biotechnology Co., Ltd 0513-66337626 18051384581
 sales@chemhifuture.com China 4209 58
Nanjing Tengyi Biotechnology Co., Ltd 025-58851786 17714337195
 sales@tybiochem.com China 5141 58
https://hanhongsci.com/ 021-54306202 18917919676
 info@hanhongsci.com China 29989 58
  • NVP-CLR457
  • 2-Oxazolidinone, 3-[2'-amino-2-(4-morpholinyl)-4'-(trifluoromethyl)[4,5'-bipyrimidin]-6-yl]-4-(hydroxymethyl)-5-methyl-, (4S,5R)-
  • (4S,5R)-3-[6-[2-amino-4-(trifluoromethyl)-5-pyrimidinyl]-2-(4-morpholinyl)-4-pyrimidinyl]-4-(hydroxymethyl)-5-methyl-2-oxazolidinone
  • 1453082-52-4
Copyright 2019 © ChemicalBook. All rights reserved